Additionally, Chen at al. studied Rho GTPase-activating protein 26 (ARHGAP26), a negative regulator of the Rho family, in a cohort of 85 ovarian cancer tissues and corresponding non-malignant regions. This evidence concerns the gene RHO and ovarian carcinoma.